Antiepileptic drugs /

Antiepileptic drugs /

Saved in:
Bibliographic Details
Edition:4th ed.
Imprint:New York : Raven Press, c1995.
Description:xxv, 1120 p. : ill. ; 29 cm.
Language:English
Subject:
Epilepsy -- Chemotherapy.
Anticonvulsants.
Anticonvulsants.
Epilepsy -- drug therapy.
Anticonvulsants.
Epilepsy -- Chemotherapy.
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/2354741
Hidden Bibliographic Details
Other authors / contributors:Levy, René H.
Mattson, Richard H, 1931-
Meldrum, Brian S.
ISBN:0781702461
Notes:Includes bibliographical references and index.

MARC

LEADER 00000cam a2200000 a 4500
001 2354741
003 ICU
005 20030520184600.0
008 951026s1995 nyua b 001 0 eng c
010 |a  94046415  
020 |a 0781702461 
035 |a (ICU)BID21315095 
040 |a DNLM/DLC  |c DLC  |d DLC  |d OrLoB-B  |d OCoLC 
041 0 |a eng 
050 0 0 |a RC374.C48  |b A58 1995 
060 0 |a QV 85 A628 1995 
082 0 0 |a 616.8/53061  |2 20 
245 0 0 |a Antiepileptic drugs /  |c editors, René H. Levy, Richard H. Mattson, Brian S. Meldrum ; consulting editors, Fritz E. Dreifuss, J. Kiffin Penry ; associate editor, B.J. Hessie. 
250 |a 4th ed. 
260 |a New York :  |b Raven Press,  |c c1995. 
300 |a xxv, 1120 p. :  |b ill. ;  |c 29 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
504 |a Includes bibliographical references and index. 
505 0 0 |t Introduction /  |r James J. Cereghino and J. Kiffin Penry --  |g 1.  |t Drug Absorption, Distribution, and Elimination /  |r Rene H. Levy, Kenneth E. Thummel and Jashvant D. Unadkat --  |g 2.  |t Biotransformation /  |r Emilio Perucca and Alan Richens --  |g 3.  |t Toxicology /  |r Gabriel L. Plaa and L. James Willmore --  |g 4.  |t Principles of Antiepileptic Drug Action /  |r Robert L. Macdonald and Brian S. Meldrum --  |g 5.  |t Neurophysiological Effects of Antiepileptic Drugs /  |r Carl W. Bazil and Timothy A. Pedley --  |g 6.  |t Use of Combined Antiepileptic Drug Therapy /  |r Harry Meinardi --  |g 7.  |t Experimental Selection, Quantification, and Evaluation of Antiepileptic Drugs /  |r H. Steve White, Jose H. Woodhead, Michael R. Franklin, Ewart A. Swinyard and Harold H. Wolf --  |g 8.  |t Design of Clinical Trials of New Antiepileptic Drugs /  |r Mogens Dam, Lennart Gram and John P. Mumford --  |g 9.  |t Selection of Antiepileptic Drug Therapy /  |r Richard H. Mattson --  |g 10.  |t How to Use Antiepileptic Drugs /  |r Roger J. Porter --  |g 11.  |t Compliance with Antiepileptic Drug Therapy /  |r Joyce A. Cramer and Richard H. Mattson --  |g 12.  |t Drug Formulations and Routes of Administration /  |r Meir Bialer and James C. Cloyd --  |g 13.  |t Laboratory Monitoring of Antiepileptic Drugs /  |r Svein I. Johannessen --  |g 14.  |t Antiepileptic Drug Management Before and After Epilepsy Surgery /  |r Susan S. Spencer and David J. Packey --  |g 15.  |t Discontinuation of Antiepileptic Drugs /  |r J. Christine Dean and J. Kiffin Penry --  |g 16.  |t Teratogenicity of Antiepileptic Drugs /  |r Richard H. Finnell, Heinz Nau and Mark S. Yerby --  |g 17.  |t Use of Antiepileptic Drugs in Children and the Elderly /  |r L. James Willmore and Olivier Dulac --  |g 18.  |t Methods of Determination of Antiepileptic Drugs /  |r Svein I. Johannessen --  |g 19.  |t Mechanisms of Action /  |r Robert J. DeLorenzo --  |g 20.  |t Chemistry and Biotransformation /  |r Thomas R. Browne and Barbara LeDuc --  |g 21.  |t Absorption, Distribution, and Excretion /  |r David M. Treiman and Dixon M. Woodbury --  |g 22.  |t Interactions with Other Drugs. Part 1: Clinical Aspects /  |r Henn Kutt --  |t Interactions with Other Drugs. Part 2: Mechanistic Aspects /  |r Rene H. Levy and Manoj Bajpai --  |g 23.  |t Clinical Use /  |r B. J. Wilder --  |g 24.  |t Toxicity /  |r Joseph Bruni --  |g 25.  |t Mephenytoin and Ethotoin /  |r Harvey J. Kupferberg --  |g 26.  |t Mechanisms of Action /  |r James W. Prichard and Bruce R. Ransom --  |g 27.  |t Chemistry and Biotransformation /  |r Gail D. Anderson and Rene H. Levy --  |g 28.  |t Absorption, Distribution, and Excretion /  |r W. Edwin Dodson and Robert S. Rust, Jr. --  |g 29.  |t Interactions with Other Drugs /  |r Henn Kutt --  |g 30.  |t Clinical Use /  |r Michael J. Painter and Lisa M. Gaus --  |g 31.  |t Toxicity /  |r Joyce A. Cramer and Richard H. Mattson --  |g 32.  |t Methylphenobarbital and Metharbital /  |r Mervyn J. Eadie and Wayne D. Hooper --  |g 33.  |t Mechanisms of Action /  |r Hans-Hasso Frey --  |g 34.  |t Chemistry and Biotransformation /  |r Blaise F. D. Bourgeois --  |g 35.  |t Absorption, Distribution, and Excretion /  |r James C. Cloyd and Ilo E. Leppik --  |g 36.  |t Interactions with Other Drugs /  |r Richard W. Fincham and Dorothy D. Schottelius --  |g 37.  |t Clinical Use /  |r Dennis B. Smith and John DeToledo --  |g 38.  |t Toxicity /  |r Ilo E. Leppik and James C. Cloyd --  |g 39.  |t Mechanisms of Action /  |r Robert L. Macdonald --  |g 40.  |t Chemistry and Biotransformation /  |r Johann W. Faigle and Karl F. Feldmann --  |g 41.  |t Absorption, Distribution, and Excretion /  |r Paolo L. Morselli --  |g 42.  |t Carbamazepine Epoxide /  |r Bradley M. Kerr and Rene H. Levy --  |g 43.  |t Interactions with Other Drugs /  |r Rene H. Levy and Colleen J. Wurden --  |g 44.  |t Clinical Use /  |r Pierre Loiseau and Bernard Duche --  |g 45.  |t Toxicity /  |r Gregory L. Holmes --  |g 46.  |t Mechanisms of Action /  |r Ruggero G. Fariello, Mario Varasi and Michael C. Smith --  |g 47.  |t Chemistry and Biotransformation /  |r Thomas A. Baillie and Pamela R. Sheffels --  |g 48.  |t Absorption, Distribution, and Excretion /  |r Rene H. Levy and Danny D. Shen --  |g 49.  |t Interactions with Other Drugs /  |r Richard D. Scheyer and Richard H. Mattson --  |g 50.  |t Clinical Use /  |r Blaise F. D. Bourgeois --  |g 51.  |t Toxicity /  |r Fritz E. Dreifuss --  |g 52.  |t Mechanisms of Action /  |r James A. Ferrendelli and Katherine D. Holland --  |g 53.  |t Chemistry and Biotransformation /  |r Francesco Pisani and Meir Bialer --  |g 54.  |t Absorption, Distribution, and Excretion /  |r Meir Bialer, Sun Xiaodong and Emilio Perucca --  |g 55.  |t Clinical Use /  |r Allan L. Sherwin --  |g 56.  |t Toxicity /  |r Fritz E. Dreifuss --  |g 57.  |t Methsuximide /  |r Thomas R. Browne --  |g 58.  |t Trimethadione /  |r John M. Pellock and Douglas A. Coulter --  |g 59.  |t Mechanisms of Action /  |r Robert L. Macdonald --  |g 60.  |t Diazepam /  |r Dieter Schmidt --  |g 61.  |t Clonazepam /  |r Susumu Sato and Beth A. Malow --  |g 62.  |t Nitrazepam /  |r Agostino Baruzzi, Roberto Michelucci and Carlo A. Tassinari --  |g 63.  |t Clorazepate /  |r Alan J. Wilensky --  |g 64.  |t Clobazam /  |r Simon D. Shorvon --  |g 65.  |t Lorazepam /  |r Richard W. Homan and David M. Treiman --  |g 66.  |t Mechanisms of Action /  |r R. Duane Sofia --  |g 67.  |t Chemistry and Biotransformation /  |r Norbert Kucharczyk --  |g 68.  |t Absorption, Distribution, and Excretion /  |r James L. Perhach and Robert C. Shumaker --  |g 69.  |t Interactions with Other Drugs /  |r Christopher R. Banfield and Rene H. Levy --  |g 70.  |t Clinical Use /  |r William H. Theodore, Peder K. Jensen and Rudolf M. F. Kwan --  |g 71.  |t Toxicity /  |r E. Martina Bebin, R. Duane Sofia and Fritz E. Dreifuss --  |g 72.  |t Mechanisms of Action /  |r Charles P. Taylor --  |g 73.  |t Chemistry, Absorption, Distribution, and Excretion /  |r Michael J. McLean --  |g 74.  |t Clinical Use /  |r David Chadwick --  |g 75.  |t Toxicity /  |r R. Eugene Ramsay --  |g 76.  |t Mechanisms of Action /  |r Michael J. Leach, George Lees and Dieter R. Riddall --  |g 77.  |t Chemistry and Biotransformation /  |r Maurice Dickins, David A. Sawyer, Timothy J. Morley and Derrick N. Parsons --  |g 78.  |t Absorption, Distribution, and Excretion /  |r Derrick N. Parsons, Maurice Dickins and Timothy J. Morley --  |g 79.  |t Interactions with Other Drugs /  |r Alan W. C. Yuen --  |g 80.  |t Clinical Use /  |r John P. Leach and Martin J. Brodie --  |g 81.  |t Toxicity /  |r Alan Richens --  |g 82.  |t Mechanisms of Action /  |r Michel J. Jung and Michael G. Palfreyman --  |g 83.  |t Chemistry, Absorption, Distribution, and Elimination /  |r Elinor Ben-Menachem --  |g 84.  |t Clinical Use /  |r Reetta Kalviainen, Esa Mervaala, Juhani Sivenius and Paavo J. Riekkinen, Sr. --  |g 85.  |t Toxicity /  |r Robert S. Fisher and John F. Kerrigan III --  |g 86.  |t Adrenocorticotrophic Hormone (ACTH) /  |r O. Carter Snead III --  |g 87.  |t Bromides /  |r Fritz E. Dreifuss --  |g 88.  |t Chlormethiazole /  |r Martin Smith and Doreen A. Jewkes --  |g 89.  |t Paraldehyde /  |r Lawrence A. Lockman --  |g 90.  |t Acetazolamide /  |r Stanley R. Resor, Jr., Louise D. Resor, Dixon M. Woodbury and John W. Kemp --  |g 91.  |t Oxcarbazepine /  |r Mogens Dam and Lisbeth H. Ostergaard --  |g 92.  |t Progabide /  |r Paolo L. Morselli, Kenneth G. Lloyd and Raffaele Palminteri --  |g 93.  |t Zonisamide /  |r Masakazu Seino, Shunsuke Naruto, Tsugutaka Ito and Hisashi Miyazaki --  |g 94.  |t Losigamone /  |r Ulrich Stein --  |g 95.  |t Remacemide Hydrochloride /  |r Bruce Clark, John B. Hutchison, Virginia Jamieson, Tracey Jones, Eugene C. Palmer and Richard D. Scheyer --  |g 96.  |t Stiripentol /  |r Pierre Loiseau and Bernard Duche --  |g 97.  |t Tiagabine /  |r Lisbeth H. Ostergaard, Lennart Gram and Mogens Dam --  |g 98.  |t Topiramate /  |r Elinor Ben-Menachem. 
650 0 |a Epilepsy  |x Chemotherapy.  |0 http://id.loc.gov/authorities/subjects/sh2008119833 
650 0 |a Anticonvulsants.  |0 http://id.loc.gov/authorities/subjects/sh85005657 
650 1 2 |a Anticonvulsants. 
650 2 2 |a Epilepsy  |x drug therapy. 
650 7 |a Anticonvulsants.  |2 fast  |0 http://id.worldcat.org/fast/fst00810472 
650 7 |a Epilepsy  |x Chemotherapy.  |2 fast  |0 http://id.worldcat.org/fast/fst00914186 
700 1 |a Levy, René H.  |0 http://id.loc.gov/authorities/names/n82251883  |1 http://viaf.org/viaf/51805614 
700 1 |a Mattson, Richard H,  |d 1931-  |0 http://id.loc.gov/authorities/names/n85028545  |1 http://viaf.org/viaf/90625578 
700 1 |a Meldrum, Brian S.  |0 http://id.loc.gov/authorities/names/n82241223  |1 http://viaf.org/viaf/92177355 
901 |a ToCBNA 
903 |a HeVa 
035 |a (OCoLC)31754515 
929 |a cat 
999 f f |i 76f02d5a-6946-5df6-82f0-7c1af22a1f7e  |s 840e9467-e2bd-55e8-bbb9-3809d9e3c90e 
928 |t Library of Congress classification  |a RC374.C48A580 1995  |l JCL  |c JCL-Sci  |i 6024664 
927 |t Library of Congress classification  |a RC374.C48A580 1995  |l JCL  |c JCL-Sci  |e CRERAR  |b 42918554  |i 4054571 
The John Crerar Library bookplate

Similar Items